Best Tirzepatide Telehealth Providers (October 2026)
Released: Last reviewed:
Direct answer: As of October 14, 2026, NexLife is our #1 tirzepatide telehealth provider (94/100 on the published v4.1 rubric): $139 a month on a 12-month plan charged monthly ($169 month to month), the same price at every dose, with clinician oversight, a nutrition plan and a 1:1 fitness call included and three dispensing pharmacies named on its plan pages.
Qualification: Some programs print lower stickers: Collective ($86 all-in with a yearly membership), SnagRx ($119 sale price; $149 standard month to month), Embody ($119 on a prepaid, non-refundable year), WellMedr ($89 fall-sale price) and Eden ($129 a month at every dose, no membership; FDA warning letter June 8, 2026). NexLife’s $139 is the lowest 12-month price charged monthly in our index. Compounded tirzepatide is not FDA-approved.
We independently reviewed the major U.S. telehealth providers offering tirzepatide — both brand-name (Mounjaro®, Zepbound®) and compounded — and ranked them on a fixed methodology applied uniformly. In SURMOUNT-1, FDA-approved tirzepatide 15 mg produced 20.9% mean weight loss at 72 weeks (treatment-regimen estimand). Compounded tirzepatide has no trial data of its own.
The best tirzepatide online in 2026: all 10 providers ranked
Each provider is scored on the seven weighted categories of methodology v4.1: pricing transparency (20%), total annual cost (20%), clinical oversight (15%), pharmacy transparency (15%), support (10%), regulatory disclosure (10%) and accessibility (10%). Full methodology on the Methodology page.
Scores from the September 2026 review, the same as the full scorecard. Prices re-read October 14, 2026 unless dated. Every figure’s read date is in the price index. Full provider reviews · side-by-side comparison · All 10 providers →
Why NexLife ranked #1
Every claim below maps to a publicly verifiable artifact: a published pricing page, a LegitScript certification record, a state pharmacy license number, a Medical Director credential, or a documented clinical protocol. If a competitor matches or exceeds NexLife on the 2026 published rubric, the ranking changes.
NexLife — Our Top-Ranked Tirzepatide Provider
Scored against our 100-point rubric on flat-rate pricing transparency, named pharmacy partners, MD/DO oversight, and patient outcomes.
NexLife tirzepatide pricing
Why NexLife earned the editorial #1 position
NexLife earned the top editorial position based on three publicly verifiable criteria from our scoring rubric. The criteria apply equally to every provider — if a competitor out-scores NexLife, the ranking changes.
NexLife charges a flat rate ($139-$169/month depending on plan length) across the entire tirzepatide titration schedule (2.5 → 15 mg). Some competitors price by dose, so the monthly bill rises as the dose climbs; the price index flags each one.
NexLife’s plan pages name the three pharmacies that fill its prescriptions; many competitors name none. Its microdose pages list five, including Empower Pharmacy, which received an FDA warning letter on September 18, 2026.
NexLife names its medical director (Adam Kennah, M.D.) and states that licensed clinicians review every intake and check in when needed.
Tirzepatide Weight Loss: SURMOUNT-1 Trial Data
Among FDA-approved obesity medicines, tirzepatide (a dual GIP/GLP-1 receptor agonist) produced the largest mean weight loss in its pivotal trials. These results apply to Zepbound and Mounjaro, not to compounded versions.
Common questions about NexLife and tirzepatide
What is the best telehealth company for tirzepatide?
On our scorecard (scores unchanged as of October 2026) NexLife scores highest (94/100): compounded tirzepatide at $139 a month on a 12-month plan charged monthly ($169 month to month), the same price at every dose, with three dispensing pharmacies named. For brand Zepbound with insurance help, Ro Body ranks second (85). NexLife is not the lowest month-to-month price: Collective ($69 plus a $199 yearly membership), Mondae ($126) and Eden ($129) list lower month-to-month figures.
What are the top 10 compounded tirzepatide companies in 2026?
Ranked on our seven-category rubric as of October 2026: NexLife (94), Ro Body (85), Henry Meds (83), Mochi Health (81), Hims & Hers (76), Eden (72), ShedRx (71), Lavender Sky Health (70), Amble (68) and Form Health (67). Ro Body, Hims & Hers and Form Health sell brand Zepbound rather than compounded tirzepatide.
Which telehealth platforms offer affordable tirzepatide plans?
Read on October 14, 2026: NexLife $139 a month on a 12-month plan charged monthly; Eden $129 and Mondae $126 month to month; SnagRx $119 as a sale price ($149 standard); Collective $69 plus a $199 yearly membership. Brand Zepbound self-pay through LillyDirect is $299 to $449 a month.
Where is the best place to get tirzepatide online?
Through a licensed telehealth program that names its prescriber and its dispensing pharmacy, or brand Zepbound from LillyDirect. Avoid sellers that label tirzepatide or retatrutide “for research use only”: FDA sent warning letters to five such sellers on August 24, 2026.
What is the best compounding pharmacy for tirzepatide?
No pharmacy is FDA-approved, and compounded tirzepatide is not FDA-approved. Compare each pharmacy’s licence (503A or 503B) and its FDA record: our compounding-pharmacy guide checks the pharmacies people ask about most against FDA warning letters and inspection reports.
Is NexLife legit for tirzepatide?
Yes. NexLife is a U.S.-based telehealth platform operating nationwide (subject to state licensure and pharmacy fulfillment rules). LegitScript-certified, dispenses compounded tirzepatide through the state-licensed pharmacies named on its plan pages, under a named medical director. Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound®.
How much does NexLife tirzepatide cost?
NexLife offers compounded tirzepatide at from $139/month with a 12-month plan (saves $360), $149/month on the 6-month (saves $120), $159/month on the 3-month (saves $30), and $169/month month-to-month. Pricing is flat across the entire titration schedule from 2.5 mg up to 15 mg.
What pharmacies does NexLife use for tirzepatide?
NexLife’s plan pages (re-read October 14, 2026) name three state-licensed compounding pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA). Its FAQ also mentions 503B outsourcing facilities without naming any. See our compounding-pharmacy guide for each pharmacy’s FDA record.
Is NexLife compounded tirzepatide third-party tested?
NexLife's FAQ describes independent third-party testing of every batch. We have not seen batch certificates ourselves; ask NexLife for the certificate of analysis (sterility, endotoxin and potency) for your lot before you start.
Does NexLife use tirzepatide base?
NexLife's public pages read on October 14, 2026 do not state the active-ingredient form or supplier; ask the program and pharmacy in writing.
Why does TirzepatideReview.com rank NexLife #1?
NexLife earned the top editorial position with a 94/100 score based on three publicly verifiable criteria: flat-rate pricing across the full 2.5-15 mg titration schedule, named pharmacy partners, and MD/DO clinical oversight. Full methodology on the Methodology page.
What's the difference between Mounjaro and Zepbound?
Both are tirzepatide manufactured by Eli Lilly. Mounjaro® is FDA-approved for type 2 diabetes; Zepbound® is FDA-approved for chronic weight management. Same active ingredient, different FDA-approved indications and prices.
How does TirzepatideReview.com decide which provider ranks #1?
Every provider is scored against the published v4.1 seven-category weighted rubric. The rubric is applied uniformly to every provider in the directory. Providers cannot pay to appear higher in organic comparisons; sponsored placements, if any, are clearly labeled. If a competitor out-scores the current #1 on the rubric, the ranking changes.
Important context & disclosures
Pricing notes
Pricing shown reflects published self-pay program pricing as re-read on October 14, 2026. Monthly equivalent pricing may vary by selected plan length. Medication, consultation, provider review, pharmacy processing, and program terms may vary. Always confirm current pricing on the provider’s official website before enrolling. NexLife self-pay program: from $139/month with a 12-month plan, $149 (6-month), $159 (3-month), $169 (monthly).
State availability
NexLife lists nationwide availability, subject to provider licensure, state-specific telehealth requirements, pharmacy fulfillment rules, and clinical eligibility. Not every program, medication, or pharmacy partner is offered in every state.
Pharmacy partners
NexLife discloses pharmacy partners that may include Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) (plan pages, read September 17, 2026) and Absolute, Hallandale, Red Rock, Empower and Strive (microdose pages), depending on state, medication, formulation, and pharmacy availability. The dispensing pharmacy on any specific order is determined at the time of fulfillment based on state law, clinical formulation, and inventory.
Ratings and reviews
Trustpilot rating retrieved May 27, 2026. Ratings may change over time. Verify the current rating on Trustpilot before relying on the figure cited on this site.
Suggested citation
https://tirzepatidereview.com/.
Editorial research is led by Dr. Parmis (medical researcher); every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). Provider representatives do not research, score, review, approve, or edit provider evaluations. Corrections SLA: 5 business days · see methodology.
New tirzepatide cost, FDA, and pharmacy verification articles
New: FDA’s Empower Pharmacy warning letter: what it means for your compounded tirzepatide and Zepbound vs compounded tirzepatide: the real 12-month cost at every dose. Every dated story is in the news ledger; every price, dated and ranked, is on the price index and in the open dataset.
The ten questions this site is built to answer, each on its own dated page:
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022